QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 26, 2021
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission File Number: 001-38000
____________________________
JELD-WEN Holding, Inc.
(Exact name of registrant as specified in its charter)
____________________________
Delaware
93-1273278
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
2645 Silver Crescent Drive
Charlotte, North Carolina28273
(Address of principal executive offices, zip code)
(704) 378-5700
(Registrant’s telephone number, including area code)
____________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (par value $0.01 per share)
JELD
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yesx No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
o
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The registrant had 99,134,214 shares of Common Stock, par value $0.01 per share, outstanding as of July 29, 2021.
When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:
10-K
Annual Report on Form 10-K for the fiscal year ended December 31, 2020
ABL Facility
Our $500 million asset-based loan revolving credit facility, dated as of October 15, 2014 and as amended from time to time, with JWI (as hereinafter defined) and JELD-WEN of Canada, Ltd., as borrowers, the guarantors party thereto, a syndicate of lenders, and Wells Fargo Bank, N.A., as administrative agent
Adjusted EBITDA
A supplemental non-GAAP financial measure of operating performance not based on any standardized methodology prescribed by GAAP that we define as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing
ASC
Accounting Standards Codification
ASU
Accounting Standards Update
AUD
Australian Dollar
Australia Senior Secured Credit Facility
Our senior secured credit facility, dated as of October 6, 2015 and as amended from time to time, with certain of our Australian subsidiaries, as borrowers, and Australia and New Zealand Banking Group Limited, as lender
BBSY
Bank Bill Swap Bid Rate
CAP
Cleanup Action Plan
CEO
Chief Executive Officer
CFO
Chief Financial Officer
CARES Act
Coronavirus Aid, Relief, and Economic Security Act enacted on March 27, 2020
Charter
Amended and Restated Certificate of Incorporation of JELD-WEN Holding, Inc.
CMI
JWI d/b/a CraftMaster Manufacturing, Inc.
COA
Consent Order and Agreement
CODM
Chief Operating Decision Maker
Common Stock
The 900,000,000 shares of common stock, par value $0.01 per share, authorized under our Charter
Corporate Credit Facilities
Collectively, our ABL Facility and our Term Loan Facility
COVID-19
A novel strain of the 2019-nCov coronavirus
Credit Facilities
Collectively, our Corporate Credit Facilities and our Australia Senior Secured Credit Facility as well as other acquired term loans and revolving credit facilities
D&O
Directors and Officers
DKK
Danish Krone
ERP
Enterprise Resource Planning
E.U.
European Union
Exchange Act
Securities Exchange Act of 1934, as amended
FASB
Financial Accounting Standards Board
GAAP
Generally Accepted Accounting Principles in the United States
GHGs
Greenhouse Gases
GILTI
Global Intangible Low-Taxed Income
JELD-WEN
JELD-WEN Holding, Inc., together with its consolidated subsidiaries where the context requires
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Onex
Onex Partners III LP and certain affiliates
PaDEP
Pennsylvania Department of Environmental Protection
PLP
Potential liability party
Preferred Stock
90,000,000 shares of Preferred Stock, par value $0.01 per share, authorized under our Charter
PSU
Performance Stock Unit
R&R
Repair and Remodel
Registration Rights Agreement
The agreement among JELD-WEN Holdings, Inc., Onex and its affiliates, and certain of our directors, executive officers and other pre-IPO stockholders entered into on October 3, 2011, as amended and restated on January 24, 2017 in connection with our IPO, and amended further on May 12, 2017 and November 12, 2017
RSU
Restricted Stock Unit
SEC
Securities and Exchange Commission
Securities Act
Securities Act of 1933, as amended
Senior Notes
$800.0 million of unsecured notes issued in December 2017 in a private placement in two tranches: $400.0 million bearing interest at 4.625% and maturing in December 2025 and $400.0 million bearing interest at 4.875% and maturing in December 2027
Senior Secured Notes
$250.0 million of senior secured notes issued in May 2020 in a private placement bearing interest at 6.25% and maturing in May 2025
SG&A
Selling, general, and administrative expenses
Tax Act
Tax Cuts and Jobs Act
Term Loan Facility
Our term loan facility, dated as of October 15, 2014, and as amended from time to time with JWI, as borrower, the guarantors party thereto, a syndicate of lenders, and Bank of America, N.A., as administrative agent
Common Stock
900,000,000 shares of common stock, with a par value of $0.01 per share
CERTAIN TRADEMARKS, TRADE NAMES, AND SERVICE MARKS
This report includes trademarks, trade names, and service marks owned by us. Our U.S. window and door trademarks include JELD-WEN®, AuraLast®, MiraTEC®, Extira®, LaCANTINATM, MMI Door®, KaronaTM, ImpactGard®, JW®, Aurora®, IWP®, True BLU®, ABSTM, Siteline®, and VPITM . Our trademarks are either registered or have been used as common law trademarks by us. The trademarks we use outside the U.S. include the Stegbar®, Regency®, William Russell Doors®, Airlite®, Trend®, The Perfect FitTM, Aneeta®, Breezway®, KolderTM ,Corinthian® and A&L Windows® marks in Australia, and Swedoor®, Dooria®, DANA®, MattioviTM, Alupan® and Domoferm® marks in Europe. ENERGY STAR® is a registered trademark of the U.S. Environmental Protection Agency. This report contains additional trademarks, trade names, and service marks of others, which are, to our knowledge, the property of their respective owners. Solely for convenience, trademarks, trade names, and service marks referred to in this report appear without the ®, ™ or SM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks, trade names, and service marks. We do not intend our use of other parties’ trademarks, trade names, or service marks to imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other parties.
(amounts in thousands, except share and per share data)
June 26, 2021
December 31, 2020
ASSETS
Current assets
Cash and cash equivalents
$
618,311
$
735,820
Restricted cash
911
774
Accounts receivable, net
619,032
477,472
Inventories
558,885
512,228
Other current assets
47,777
34,359
Total current assets
1,844,916
1,760,653
Property and equipment, net
846,180
872,585
Deferred tax assets
191,523
199,194
Goodwill
630,158
639,867
Intangible assets, net
239,462
246,055
Operating lease assets, net
222,012
214,727
Other assets
30,140
31,604
Total assets
$
4,004,391
$
3,964,685
LIABILITIES AND EQUITY
Current liabilities
Accounts payable
$
346,521
$
269,891
Accrued payroll and benefits
159,740
151,742
Accrued expenses and other current liabilities
354,577
379,289
Current maturities of long-term debt
42,336
66,702
Total current liabilities
903,174
867,624
Long-term debt
1,677,247
1,701,340
Unfunded pension liability
109,628
115,077
Operating lease liability
184,417
177,491
Deferred credits and other liabilities
96,179
91,368
Deferred tax liabilities
7,293
7,321
Total liabilities
2,977,938
2,960,221
Commitments and contingencies (Note 19)
Shareholders’ equity
Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding
—
—
Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 99,131,782 shares outstanding as of June 26, 2021; 900,000,000 shares authorized, par value $0.01 per share, 100,806,068 shares outstanding as of December 31, 2020
991
1,008
Additional paid-in capital
706,114
690,687
Retained earnings
400,783
371,462
Accumulated other comprehensive loss
(81,435)
(58,693)
Total shareholders’ equity
1,026,453
1,004,464
Total liabilities and shareholders’ equity
$
4,004,391
$
3,964,685
The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Description of Company and Summary of Significant Accounting Policies
Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows, doors, and other building products that derives substantially all of its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries.
We have facilities located in the U.S., Canada, Europe, Australia, Asia, and Mexico. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe, Australia, and Asia.
Our revenues are affected by the level of new housing starts and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain areas of our geographic end markets.
Basis of Presentation – The accompanying unaudited consolidated financial statements as of June 26, 2021 and for the three and six months ended June 26, 2021 and June 27, 2020, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three and six months ended June 26, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021, or any other period. The accompanying consolidated balance sheet as of December 31, 2020 was derived from audited financial statements included in the Company’s Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020.
All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted.
Ownership – As of December 31, 2020, Onex owned approximately 33% of the outstanding shares of our Common Stock. On March 1, 2021 and May 10, 2021, Onex exercised its rights under its Registration Rights Agreement and requested the registration for resale of 8,000,000 and 10,000,000 shares of our Common Stock, respectively, in underwritten public offerings (the “Secondary Offerings”), and as provided under the terms of the Registration Rights Agreement, we were responsible for all related fees and expenses except for the underwriters’ discounts and commissions, which were paid by Onex. The Secondary Offerings were completed on March 3, 2021 and May 13, 2021. After the Secondary Offerings, Onex held approximately 25% and 15% of our outstanding shares of Common Stock, respectively. In addition, in connection with the Secondary Offerings, the Company purchased from the underwriter 800,000 and 1,000,000 of the aggregate shares of our Common Stock that were the subject of the Secondary Offerings at a price per share of $28.61 and $28.80, respectively, which is the price at which the underwriter purchased the shares from Onex in the Secondary Offerings.
Fiscal Year– We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
COVID-19 – The CARES Act in the U.S. and similar legislation in other jurisdictions includes measures that assist companies in responding to the COVID-19 pandemic. These measures consisted primarily of cash assistance to support employment levels and deferment of remittance of certain non-income tax expense payments. The most significant impact was the CARES Act in the U.S., which included a provision that allows employers to defer the remittance of the employer portion of the social security tax. The deferred employment tax must be paid over two years, with half of the amount required to be paid by December 31, 2021 and the other half by December 31, 2022. For the year ended December 31, 2020, the Company deferred $20.9 million of the employer portion of social security tax. As of June 26, 2021 and December 31, 2020, $10.4 million is included in accrued payroll and benefits and the remaining is included in deferred credits and other liabilities and in the consolidated balance sheet. For our Europe and Australasia regions, the deferrals totaled approximately $4.9 million and $1.5 million, respectively, at June 26, 2021 and $11.5 million and $1.8 million, respectively at December 31, 2020. The impact of the CARES Act and similar legislation in prospective periods may differ from our estimates as of June 26, 2021 due to changes in interpretations and assumptions, guidance that may be issued, and actions we may take in respect to these measures. The CARES Act and similar legislation in other jurisdictions are highly detailed and we will continue to assess the impact that various provisions will have on our business.
Recently Adopted Accounting Standards – In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain exceptions to the general principles of ASC 740, including, but not limited to, accounting relating to intraperiod tax allocations, deferred tax liabilities related to outside basis differences, and year to date losses in interim periods. This guidance is effective for fiscal years beginning after December 15, 2020. We adopted this standard in the first quarter of 2021 and the adoption did not have an impact on our unaudited consolidated financial statements as of the date of adoption.
In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of LIBOR or by another reference rate expected to be discontinued. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, to clarify the scope of ASU No. 2020-04. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. In May 2020, we elected the expedient within ASC 848 which allows us to assume that our hedged interest payments are probable of occurring regardless of any expected modifications in their terms related to reference rate return. In addition, ASC 848 allows for the option to change the method of assessing effectiveness upon a change in critical terms of the derivative or the hedged transactions and upon the end of relief under ASC 848. At this time, we have elected to continue the method of assessing effectiveness as documented in the original hedge documentation and apply the practical expedients related to probability to assume that the reference rate on the hypothetical derivative matches the reference rate on the hedging instrument. We plan to evaluate the remaining expedients for adoption, as applicable, when contracts are modified. We currently do not expect this guidance to have a significant impact on our consolidated financial statements. Refer to Note 17 – Derivative Financial Instruments for additional disclosure information relating to our hedging activity.
We have considered the applicability and impact of all ASUs. We have assessed ASUs not listed above and have determined that they were either not applicable or were not expected to have a material impact on our financial statements.
Note 2. Accounts Receivable
We sell our manufactured products to a large number of customers, primarily in the residential housing construction and remodel sectors, broadly dispersed across many domestic and foreign geographic regions. We assess the credit risk relating to our accounts receivable based on quantitative and qualitative factors, primarily historical credit collections within each region where we have operations. We perform ongoing credit evaluations of our customers to minimize credit risk. We do not usually require collateral for accounts receivable, but will require advance payment, guarantees, a security interest in the products sold to a customer, and/or letters of credit in certain situations. Customer accounts receivable converted to notes receivable are collateralized by inventory or other collateral.
At June 26, 2021 and December 31, 2020, we had an allowance for doubtful accounts of $13.5 million and $12.9 million, respectively.
Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs.
(amounts in thousands)
June 26, 2021
December 31, 2020
Raw materials
$
410,429
$
382,698
Work in process
40,580
35,712
Finished goods
107,876
93,818
Total inventories
$
558,885
$
512,228
Note 4. Property and Equipment, Net
(amounts in thousands)
June 26, 2021
December 31, 2020
Property and equipment
$
2,228,258
$
2,222,008
Accumulated depreciation
(1,382,078)
(1,349,423)
Total property and equipment, net
$
846,180
$
872,585
We recorded impairment charges of $0.9 million and $1.2 million for the three and six months ended June 26, 2021, respectively. We recorded impairment charges of $0.6 million and $1.5 million for the three and six months ended June 27, 2020, respectively.
Depreciation expense was recorded as follows:
Three Months Ended
Six Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
June 26, 2021
June 27, 2020
Cost of sales
$
23,707
$
21,784
$
46,243
$
43,525
Selling, general and administrative
2,398
2,039
4,794
4,668
Total depreciation expense
$
26,105
$
23,823
$
51,037
$
48,193
Note 5. Goodwill
The following table summarizes the changes in goodwill by reportable segment:
The cost and accumulated amortization values of our intangible assets were as follows:
June 26, 2021
(amounts in thousands)
Cost
Accumulated Amortization
Net Book Value
Customer relationships and agreements
$
152,685
$
(72,645)
$
80,040
Software
115,221
(30,504)
84,717
Trademarks and trade names
60,022
(11,029)
48,993
Patents, licenses and rights
48,220
(22,508)
25,712
Total amortizable intangibles
$
376,148
$
(136,686)
$
239,462
December 31, 2020
(amounts in thousands)
Cost
Accumulated Amortization
Net Book Value
Customer relationships and agreements
$
155,006
$
(68,186)
$
86,820
Software
106,697
(26,801)
79,896
Trademarks and trade names
60,699
(9,821)
50,878
Patents, licenses and rights
48,759
(20,298)
28,461
Total amortizable intangibles
$
371,161
$
(125,106)
$
246,055
Through June 26, 2021, we have capitalized software costs of $84.7 million related to the application development stage of our global ERP system implementation, including $8.7 million during the six months ended June 26, 2021. In March 2020, we impaired $3.4 million of capitalized software within impairment and restructuring charges in the accompanying unaudited consolidated statements of operations due to delays in implementation of certain ERP modules and the uncertainty of its future. In the third quarter of 2020, we reduced the estimated useful life of our initial ERP instance from 15 years to 10 years to align with our current plans for our future global ERP system. In the fourth quarter of 2020, we placed in service and began amortizing our current global ERP instance over its estimated useful life of 10 years. As of June 26, 2021, we have placed $78.5 million in service and are amortizing the cost of our global ERP system over its estimated useful life.
Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable. Intangible assets that become fully amortized are removed from the accounts in the period that they become fully amortized. Amortization expense was recorded as follows:
Note 7. Accrued Expenses and Other Current Liabilities
(amounts in thousands)
June 26, 2021
December 31, 2020
Accrued sales and advertising rebates
$
82,990
$
87,030
Legal claims provision
82,918
108,629
Current portion of operating lease liability
46,030
44,319
Non-income related taxes
35,167
31,436
Current portion of warranty liability (Note 8)
23,082
21,766
Accrued expenses
18,818
15,751
Accrued freight
18,056
18,967
Deferred revenue
17,441
13,453
Current portion of accrued claim costs relating to self-insurance programs
11,848
11,882
Accrued income taxes payable
8,004
11,224
Current portion of derivative liability (Note 17)
5,069
9,778
Accrued interest payable
4,124
3,681
Current portion of restructuring accrual (Note 15)
1,030
1,373
Total accrued expenses and other current liabilities
$
354,577
$
379,289
The legal claims provision relates primarily to contingencies associated with the ongoing legal matters disclosed in Note 19 – Commitments and Contingencies.
The accrued sales and advertising rebates, accrued interest payable, accrued freight, and non-income related taxes can fluctuate significantly period-over-period due to timing of payments.
Note 8. Warranty Liability
Warranty terms vary from one year to lifetime on certain window and door components. Warranties are normally limited to servicing or replacing defective components for the original customer. Product defects arising within six months of sale are classified as manufacturing defects and are not included in the current period expense below. Some warranties are transferable to subsequent owners and are either limited to 10 years from the date of manufacture or require pro-rata payments from the customer. A provision for estimated warranty costs is recorded at the time of sale based on historical experience and is periodically adjusted to reflect actual experience.
An analysis of our warranty liability is as follows:
(amounts in thousands)
June 26, 2021
June 27, 2020
Balance as of January 1
$
52,296
$
49,716
Current period charges
13,740
10,024
Experience adjustments
2,601
2,293
Payments
(14,984)
(11,985)
Currency translation
109
(381)
Balance at period end
53,762
49,667
Current portion
(23,082)
(20,310)
Long-term portion
$
30,680
$
29,357
The most significant component of our warranty liability is in the North America segment, which totaled $46.7 million at June 26, 2021, after discounting future estimated cash flows at rates between 0.53% and 4.75%. Without discounting, the liability would have been higher by approximately $2.2 million.
Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following:
June 26, 2021
June 26, 2021
December 31, 2020
(amounts in thousands)
Interest Rate
Senior Secured Notes and Senior Notes
4.63% - 6.25%
$
1,050,000
$
1,050,000
Term loans
1.30% - 2.09%
548,916
588,881
Finance leases and other financing arrangements
1.25% - 5.95%
104,650
113,174
Mortgage notes
1.65%
28,053
29,296
Total Debt
1,731,619
1,781,351
Unamortized debt issuance costs and original issue discounts
(12,036)
(13,309)
Current maturities of long-term debt
(42,336)
(66,702)
Long-term debt
$
1,677,247
$
1,701,340
Summaries of our significant changes to outstanding debt agreements as of June 26, 2021 are as follows:
Senior Secured Notes and Senior Notes
In May 2020, we issued $250.0 million of Senior Secured Notes bearing interest at 6.25% and maturing in May 2025 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance, including an underwriting fee of 1.25%. Interest is payable semiannually, in arrears, each May and November through maturity, which began November 2020.
In December 2017, we issued $800.0 million of unsecured Senior Notes in two tranches: $400.0 million bearing interest at 4.63% and maturing in December 2025, and $400.0 million bearing interest at 4.88% and maturing in December 2027 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act.
Term Loans
U.S. Facility - In December 2017, along with the issuance of the Senior Notes, we re-priced and amended the facility, which resulted in a principal balance of $440.0 million. These re-priced term loans were offered at par and bear interest at the rate of LIBOR (subject to a floor of 0.00%) plus a margin of 1.75% to 2.00%, determined by our corporate credit ratings. This amendment also modified other terms and provisions, including providing for additional covenant flexibility and additional capacity under the facility.
In February 2019, we purchased interest rate caps in order to effectively fix a 3.0% per annum ceiling on the LIBOR component of an aggregate $150.0 million of our term loans. The caps became effective March 2019 and expire December 2021.
In September 2019, we amended the Term Loan Facility to provide for an incremental aggregate principal amount of $125.0 million and used the proceeds primarily to repay $115.0 million of outstanding borrowings under the ABL Facility. The proceeds were net of the original issue discount of 0.5%, or $0.6 million, as well as $0.6 million in fees and expenses associated with the debt issuance. This amendment requires that approximately $1.4 million of the aggregate principal amount be repaid quarterly until the maturity date. At June 26, 2021, the outstanding principal balance, net of original issue discount, was $548.1 million.
On July 28, 2021, we amended the Term Loan Facility to, among other things, extend the maturity date from December 2024 to July 2028 and provide additional covenant flexibility. Pursuant to the amendment, certain existing and new lenders advanced $550.0 million of replacement term loans, the proceeds of which were used to prepay in full the amount outstanding under the existing term loans. The replacement term loans bear interest at LIBOR (subject to a floor of 0.00%) plus a margin of 2.00% to 2.25% depending on JWI’s corporate credit rating. In addition, the amendment also modifies certain other terms and provisions of the Term Loan Facility. Voluntary prepayments of the replacement term loans are permitted at any time, in certain minimum principal amounts, but are subject to a 1.00% premium during the first six months. As of the date of the amendment, the outstanding principal balance, net of original issue discount, was $548.6 million.
In May 2020, we entered into interest rate swap agreements with a weighted average fixed rate of 0.395% paid against one-month LIBOR floored at 0.00% with outstanding notional amounts aggregating to $370.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate swap agreements are designated as cash
flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and mature in December 2023. See Note 17 – Derivative Financial Instruments for additional information on our derivative assets and liabilities.
Australia Facility - In June 2019, we reallocated AUD 5.0 million from the term loan commitment to the interchangeable commitment of the Australia Senior Secured Credit Facility. The amended AUD 50.0 million floating rate term loan facility, bore interest at a base rate of BBSY plus a margin ranging from 1.00% to 1.10%, and included a line fee of 1.25% on the commitment amount and was set to mature in February 2023. During the quarter, we repaid the outstanding principal balance of AUD 50.0 million ($38.4 million). This facility had no outstanding principal balance as of June 26, 2021. There are no additional borrowings permitted under this facility.
Both the term loan and non-term loan portions of the Australia Senior Secured Credit Facility are or were secured by guarantees of JWA and its subsidiaries, fixed and floating charges on the assets of JWA group, and mortgages on certain real properties owned by the JWA group. The combined agreement requires that JWA maintain certain financial ratios, including a minimum consolidated interest coverage ratio and a maximum consolidated debt to EBITDA ratio. The agreement limits dividends and repayments of intercompany loans where the JWA group is the borrower and limits acquisitions without the bank’s consent.
Revolving Credit Facilities
ABL Facility - In December 2019, we amended the ABL facility, a $400.0 million asset-based loan revolving credit facility maturing in December 2022, which did not have a financial impact. This facility bears interest primarily at LIBOR (subject to a floor of 0.00%) plus a margin of 1.25% to 1.75%, determined by availability. Extensions of credit are limited by a borrowing base calculated based on specified percentages of the value of eligible accounts receivable and inventory, subject to certain reserves and other adjustments. We pay a fee of 0.25% on the unused portion of the commitments. The ABL Facility has a minimum fixed charge coverage ratio that we are obligated to comply with under certain circumstances. The ABL Facility has various non-financial covenants, including restrictions on liens, indebtedness, dividends, customary representations and warranties, and share repurchases, as well as customary events of defaults and remedies.
In March 2020, we drew $100.0 million under our ABL Facility as a precautionary measure to ensure funding of our seasonal working capital cash requirements given the significant impact of the COVID-19 pandemic on global financial markets and economies. In May 2020, we utilized a portion of the proceeds received from our issuance of the $250.0 million of Senior Secured Notes to repay the outstanding balance on our ABL Facility. In the fourth quarter of 2020, we began to include the accounts receivable and inventory balances of certain recently acquired U.S. businesses in determining our availability, which expanded our borrowing base. As of June 26, 2021, we had no outstanding borrowings, $36.3 million in letters of credit and $363.6 million available under the ABL Facility.
On July 28, 2021, we amended the ABL Facility to, among other things, extend the maturity date from December 2022 to July 2026, increase the aggregate commitment to $500.0 million, reduce the interest rate applicable to the loans thereunder, provide additional covenant flexibility, and conform certain terms and provisions to the Term Loan Facility. Pursuant to the amendment, the amount allocated to U.S. borrowers was increased to $465.0 million. The amount that could be allocated to Canadian borrowers was maintained at $35.0 million. Borrowings under the ABL Facility bear, at the borrower’s option, interest at either a base rate plus a margin of 0.25% to 0.50% depending on excess availability or LIBOR plus a margin of 1.25% to 1.50% depending on excess availability.
Australia Senior Secured Credit Facility -In June 2019, we amended the Australia Senior Secured Credit Facility, reallocating availability from the Australia Term Loan Facility and collapsing the floating rate revolving loan facility into an AUD 35.0 million interchangeable facility to be used for guarantees, asset financing, and loans of 12 months or less. The interchange facility no longer has a set maturity date but is instead subject to an annual review. In May 2020, we amended the Australia Senior Secured Credit Facility to relax certain financial covenants and renew the non-term loan portion of the facility to at least June 2021. The amended non-term loan portion of the facility bore line fees of 0.70%, compared to a line fee of 0.50% under the previous amendment. As of June 26, 2021, we had AUD 22.9 million ($17.3 million) available under this facility.
The amendment also provided for a supplemental AUD 30.0 million floating rate revolving loan facility to be used for loans bearing interest at BBSY plus a margin of 1.10%, and a line fee of 0.90%, and maturing on June 30, 2021. The facility may be used only if and when the AUD 35.0 million interchangeable facility is fully utilized. As of June 26, 2021, we had AUD 30.0 million ($22.8 million) available under this facility.
At June 26, 2021, we had combined borrowing availability of $403.7 million under our revolving credit facilities.
Mortgage Notes – In December 2007, we entered into thirty-year mortgage notes secured by land and buildings with principal payments which began in 2018. At June 26, 2021, we had DKK174.7 million ($28.1 million) outstanding under these notes.
Finance leases and other financing arrangements–In addition to finance leases, we include insurance premium financing arrangements and loans secured by equipment in this category. At June 26, 2021, we had $104.7 million outstanding in this category, with maturities ranging from 2021 to 2028.
As of June 26, 2021, we were in compliance with the terms of all of our credit facilities and the indentures governing the Senior Notes and Senior Secured Notes.
Note 10. Income Taxes
The Company previously completed its accounting for the income tax effects of the Tax Act. We have considered ongoing developments released through the date hereof and determined that they have no material impact on our tax accounts for the six months ended June 26, 2021. Final guidance, once issued, may materially affect our conclusions regarding the net related effects of the Tax Act on our unaudited consolidated financial statements. Until then, management will continue to monitor and work with its tax advisors to interpret any guidance issued.
The effective income tax rate for continuing operations was 26.9% and 27.5% for the three and six months ended June 26, 2021, respectively, compared to 31.1% and 33.7% for the three and six months ended June 27, 2020, respectively. In accordance with ASC 740-270, we recorded tax expense of $22.4 million and $32.7 million from operations in the three and six months ended June 26, 2021, respectively, compared to a tax expense of $10.4 million and $11.6 million in the three and six months ended June 27, 2020, respectively, by applying an estimated annual effective tax rate to our year-to-date income for includable entities during the respective periods. Our estimated annual effective tax rate for both years includes the impact of the tax on GILTI. The application of the estimated annual effective tax rate in interim periods may result in a significant variation in the customary relationship between income tax expense and pretax accounting income due to the seasonality of our global business. Entities that are currently generating losses and for which there is a full valuation allowance are excluded from the worldwide effective tax rate calculation and are calculated separately.
The impact of significant discrete items is separately recognized in the quarter in which they occur. The tax benefit for discrete items included in the tax provision for continuing operations for the three months ended June 26, 2021 was $1.7 million compared to $2.9 million of tax benefit for the three months ended June 27, 2020, respectively. The discrete amounts for the three months ended June 26, 2021 were comprised primarily of $1.8 million of tax benefit related to future changes to the UK tax rate enacted in the current period, a tax benefit of $0.3 million attributable to a windfall tax deduction on share-based compensation, partially offset by tax expense of $0.3 million attributable to current period interest expense on uncertain tax positions. The discrete amounts for the three months ended June 27, 2020 were comprised primarily of $3.9 million of tax benefit attributed to the expiration of the statute of limitations on certain years in Estonia, partially offset by tax expense of $0.4 million attributable to the shortfall recognized from exercises and forfeitures from share-based compensation awards, $0.3 million attributable to interest expense on uncertain tax positions, and $0.3 million attributed to the deferred tax impact of tax rate reductions.
The tax benefit related to discrete items included in the tax provision for continuing operations for the six months ended June 26, 2021 was $1.6 million, compared to $2.1 million for the six months ended June 27, 2020. The discrete tax benefits for the six months ended June 26, 2021 were comprised primarily of $1.8 million of tax benefit related to future changes to the UK tax rate enacted in the current period, a tax benefit of $0.5 million attributable to a windfall tax deduction on share-based compensation, partially offset by tax expense of $0.6 million attributable to current period interest expense on uncertain tax positions. The discrete benefit amounts for the six months ended June 27, 2020 were comprised primarily of $3.9 million of tax benefit attributed to the expiration of the statute of limitations on certain years in Estonia, partially offset by $1.1 million attributable to interest expense on uncertain tax positions, $0.4 million attributable to the shortfall recognized from exercises and forfeitures from share-based compensation awards, and $0.3 million attributed to the deferred tax impact of tax rate reductions.
Under ASC 740-10, we provide for uncertain tax positions and the related interest expense by adjusting unrecognized tax benefits and accrued interest accordingly. We recognize potential interest and penalties related to unrecognized tax benefits in income tax expense. We had unrecognized tax benefits without regard to accrued interest of $20.6 million and $17.0 million as of June 26, 2021 and December 31, 2020, respectively. The increase is primarily related to an increase in management’s assessment of a potential liability as a result of ongoing tax audit discussions in Europe. In addition, the Company recorded a deferred tax asset based on the same tax audit to reflect certain benefits that should result from agreements currently in place between members of the E.U.
There are no changes to the Company’s indefinite reinvestment assertion on unremitted earnings, as outlined at December 31, 2020. However, with the continued uncertainty in the global economy due to the COVID-19 pandemic and impact on the Company’s business operations and liquidity, the Company may consider changes to this position in future periods as the Company’s outlook or operational needs change.
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC 280-10- Segment Reporting. We determined that we have three reportable segments, organized and managed principally by geographic region. Our reportable segments are North America, Europe, and Australasia. We report all other business activities in Corporate and unallocated costs. Factors considered in determining the three reportable segments include the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information available and the information regularly reviewed by the CODM. Management reviews net revenues and Adjusted EBITDA to evaluate segment performance and allocate resources. We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other items; other non-cash items; and costs related to debt restructuring and debt refinancing.
The following tables set forth certain information relating to our segments’ operations:
Reconciliations of net income to Adjusted EBITDA are as follows:
Three Months Ended
Six Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
June 26, 2021
June 27, 2020
Net income
$
60,710
$
23,097
$
86,195
$
22,867
Income tax expense
22,359
10,403
32,718
11,600
Depreciation and amortization
35,465
32,771
69,675
66,217
Interest expense, net
18,860
19,076
37,315
35,680
Impairment and restructuring charges(1)
1,415
2,343
2,342
9,038
(Gain) loss on sale of property and equipment
1,308
(337)
432
(2,410)
Share-based compensation expense
7,526
5,162
14,381
8,895
Non-cash foreign exchange transaction/translation (income) loss
(2,000)
8,784
(13,496)
7,595
Other items (2)
2,599
24,250
16,591
40,575
Costs relating to debt restructuring and debt refinancing
—
170
—
170
Adjusted EBITDA
$
148,242
$
125,719
$
246,153
$
200,227
(1)Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our accompanying unaudited consolidated statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are included in cost of sales in our accompanying unaudited consolidated statements of operations were $270 and $77for the three months ended June 26, 2021 and June 27, 2020, respectively, and $270 and $227for the six months ended June 26, 2021 and June 27, 2020, respectively. For further explanation of impairment and restructuring charges that are included in our unaudited consolidated statements of operations, see Note 15 - Impairment and Restructuring Charges in our financial statements.
(2)Other non-recurring items not core to ongoing business activity include: (i)in the three months ended June 26, 2021 (1) $1,531 in legal costs and professional expenses relating primarily to litigation, and (2) $654 in facility closure, consolidation, startup, and other related costs;(ii) in the three months endedJune 27, 2020 (1) $22,994 in legal costs and professional expenses relating primarily to litigation, and (2) $967 in facility closure, consolidation, startup, and other related costs; (iii) in the six months ended June 26, 2021 (1) $15,286 in legal costs and professional expenses relating primarily to litigation, and (2) $783 in facility closure, consolidation, startup, and other related costs; (iv) in the six months ended June 27, 2020 (1) $34,700 in legal costs and professional expenses relating primarily to litigation, (2) $4,077 in facility closure, consolidation, startup, and other related costs, and (3) $1,235 in one-time lease termination charges.
Note 12. Capital Stock
Preferred Stock - Our Board of Directors is authorized to issue Preferred Stock from time to time in one or more series and with such rights, privileges, and preferences as the Board of Directors shall from time to time determine. We have not issued any shares of Preferred Stock.
Common Stock - Common Stock includes the basis of shares outstanding plus amounts recorded as additional paid-in capital. Shares outstanding exclude the shares issued to the Employee Benefit Trust that are considered similar to treasury shares and total 193,941 shares at both June 26, 2021 and December 31, 2020 with a total original issuance value of $12.4 million.
We record share repurchases on their trade date and reduce shareholders’ equity and increase accounts payable. Repurchased shares are retired, and the excess of the repurchase price over the par value of the shares is charged to retained earnings.
On November 4, 2019, our Board of Directors increased the authorization under our existing share repurchase program to a total of $175.0 million with no expiration date.
On July 27, 2021, the Board of Directors authorized an increase to the remaining authorization to a total of $400.0 million with no expiration date.
During the three and six months ended June 26, 2021, we repurchased 1,177,757 and 1,987,641 shares of our Common Stock, respectively, at an average price per share of $28.66 and $28.62, respectively. We did not repurchase shares during the three months ended June 27, 2020. During the six months ended June 27, 2020, we repurchased 265,589 shares of our Common Stock at an average price per share of $18.83.
The basic and diluted income per share calculations were determined based on the following share data:
Three Months Ended
Six Months Ended
June 26, 2021
June 27, 2020
June 26, 2021
June 27, 2020
Weighted average outstanding shares of Common Stock basic
99,514,890
100,508,707
99,991,045
100,576,621
Restricted stock units, performance share units, and options to purchase Common Stock
2,155,734
425,566
2,150,844
727,354
Weighted average outstanding shares of Common Stock diluted
101,670,624
100,934,273
102,141,889
101,303,975
The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive:
The activity under our incentive plans for the periods presented are reflected in the following tables:
Three Months Ended
June 26, 2021
June 27, 2020
Shares
Weighted Average Exercise Price Per Share
Shares
Weighted Average Exercise Price Per Share
Options granted
—
$
—
6,613
$
9.55
Options canceled
9,000
$
31.93
74,686
$
26.55
Options exercised
64,511
$
16.25
8,942
$
8.57
Shares
Weighted Average Grant Date Fair Value
Shares
Weighted Average Grant Date Fair Value
RSUs granted
59,690
$
30.51
105,123
$
11.93
PSUs granted
—
$
—
6,175
$
9.92
Six Months Ended
June 26, 2021
June 27, 2020
Shares
Weighted Average Exercise Price Per Share
Shares
Weighted Average Exercise Price Per Share
Options granted
309,902
$
29.01
407,607
$
24.30
Options canceled
25,602
$
28.15
116,175
$
26.05
Options exercised
153,573
$
15.00
104,380
$
11.61
Shares
Weighted Average Grant Date Fair Value
Shares
Weighted Average Grant Date Fair Value
RSUs granted
642,609
$
29.15
686,915
$
19.52
PSUs granted
165,749
$
30.70
311,275
$
25.19
Stock-based compensation expense was $7.5 million and $14.4 million for the three and six months ended June 26, 2021, respectively, and $5.2 million and $8.9 million for the three and six months ended June 27, 2020, respectively. As of June 26, 2021, we had $38.1 million of total unrecognized compensation expense related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the remaining weighted-average vesting period of 1.68 years.
Note 15. Impairment and Restructuring Charges
We engage in restructuring activities intended to improve productivity, operating margins, and working capital levels. Restructuring costs primarily relate to workforce reductions, repositioning of management structure, and costs associated with plant consolidations and closures.
In the six months ended June 27, 2020, impairment charges primarily related to capitalized costs of certain ERP modules due to delays in implementation and uncertainty of their future use.
The table below summarizes the amounts included in other income in the accompanying unaudited consolidated statements of operations:
Three Months Ended
Six Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
June 26, 2021
June 27, 2020
Foreign currency losses (gains)
$
297
$
6,324
$
(8,936)
$
4,074
Governmental pandemic assistance reimbursement
(235)
(5,881)
(499)
(5,881)
Loss (gain) on sale or disposal of business units, property, and equipment
1,308
(337)
362
(2,410)
Pension (income) expense
(40)
(2,156)
(76)
631
Other items
(1,178)
(448)
(1,540)
(1,243)
Total other expense (income)
$
152
$
(2,498)
$
(10,689)
$
(4,829)
Governmental pandemic assistance reimbursement for the three and six months ended June 26, 2021 and June 27, 2020 primarily consisted of cash received from governmental pandemic assistance programs within our North America and Europe segments as a result of COVID-19.
Note 17. Derivative Financial Instruments
Foreign currency derivatives – We are exposed to the impact of foreign currency fluctuations in certain countries in which we operate. In most of these countries, the exposure to foreign currency movements is limited because the operating revenues and expenses of our business units are substantially denominated in the local currency. To the extent borrowings, sales, purchases, or other transactions are not executed in the local currency of the operating unit, we are exposed to foreign currency risk. To mitigate the exposure, we enter into a variety of foreign currency derivative contracts, such as forward contracts, option collars, and cross-currency hedges. To manage the effect of exchange fluctuations on forecasted sales, purchases, acquisitions, inventory and capital expenditures, and certain intercompany transactions that are denominated in foreign currencies, we have foreign currency derivative contracts with a total notional amount of $113.0 million. We have foreign currency derivative contracts, with a total notional amount of $23.2 million, to hedge the effects of translation gains and losses on intercompany loans and interest. To mitigate the impact to the consolidated earnings of the Company from the effect of the translation of certain subsidiaries’ local currency results into U.S. dollars, we have foreign currency derivative contracts with a total notional amount of $112.6 million. We do not use derivative financial instruments for trading or speculative purposes. We have not elected hedge accounting for any foreign currency derivative contracts. We record mark-to-market changes in the values of these derivatives in other expense (income). We recorded mark-to-market gains of $2.0 million and $5.8 million in the three and six months ended June 26, 2021, respectively, and losses of $12.6 million and gains of $3.2 million in the three and six months ended June 27, 2020, respectively.
Interest rate derivatives – We are exposed to interest rate risk in connection with our variable rate long-term debt and partially mitigate this risk through interest rate derivatives such as swaps and caps. In May 2020, we entered into interest rate swap agreements to manage this risk. The interest rate swaps have outstanding notional amounts aggregating to $370.0 million and mature in December 2023 with a weighted average fixed rate of 0.395% paid against one-month USD LIBOR floored at 0.00%. The interest rate swap agreements are designated as cash flow hedges and effectively fix the interest rate on a corresponding portion of the aggregate debt outstanding under our Term Loan Facility.
No portion of these interest rate contracts were deemed ineffective during the three and six months ended June 26, 2021. We recorded pre-tax mark-to-market gains in other comprehensive income of $0.3 million and $1.4 million during the three and six months ended June 26, 2021, respectively, and pre-tax mark-to-market losses of $1.7 million during the three and six months ended June 27, 2020. We reclassified losses of $0.3 million and $0.5 million previously recorded in other comprehensive income to interest expense during the three and six months ended June 26, 2021, respectively. There were no amounts reclassified during the three and six months ended June 27, 2020.
As of June 26, 2021, approximately $1.0 million is expected to be reclassified to interest expense over the next 12 months.
The derivative agreements each contain a provision whereby we could be declared in default on our derivative obligations if we either default or, in certain cases, are capable of being declared in default of any of our indebtedness greater than specified thresholds. These agreements also contain a provision where we could be declared in default subsequent to a merger or restructuring type event if the creditworthiness of the resulting entity is materially weaker.
During the first quarter of 2019, we entered into two interest rate cap contracts against three-month USD LIBOR, each with a cap rate of 3.00%. These caps have a combined notional amount of $150.0 million, became effective in March 2019, and terminate in December 2021. We have not elected hedge accounting and have recorded insignificant mark-to-market adjustments in the three and six months ended June 26, 2021 and June 27, 2020.
The fair values of derivative instruments held are as follows:
Derivative assets
(amounts in thousands)
Balance Sheet Location
June 26, 2021
December 31, 2020
Derivatives designated as hedging instruments:
Interest rate contracts
Other assets
$
971
$
—
Derivatives not designated as hedging instruments:
Foreign currency forward contracts
Other current assets
$
1,666
$
542
Derivatives liabilities
(amounts in thousands)
Balance Sheet Location
June 26, 2021
December 31, 2020
Derivatives designated as hedging instruments:
Interest rate contracts
Accrued expenses and other current liabilities
$
899
$
955
Interest rate contracts
Deferred credits and other liabilities
$
—
$
897
Derivatives not designated as hedging instruments:
Foreign currency forward contracts
Accrued expenses and other current liabilities
$
4,170
$
8,823
Note 18. Fair Value of Financial Instruments
We record financial assets and liabilities at fair value based on FASB guidance related to fair value measurements. The guidance requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Three levels of inputs may be used to measure fair value:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Quoted market-based inputs or unobservable inputs that are corroborated by market data.
Level 3 – Unobservable inputs that are not corroborated by market data.
The recorded carrying amounts and fair values of these instruments were as follows:
June 26, 2021
(amounts in thousands)
Carrying Amount
Total Fair Value
Level 1
Level 2
Level 3
Assets:
Cash equivalents
$
325,354
$
325,354
$
—
$
325,354
$
—
Derivative assets, recorded in other current assets
1,666
1,666
—
1,666
—
Derivative assets, recorded in other assets
971
971
—
971
—
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt
$
1,731,619
$
1,772,123
$
—
$
1,772,123
$
—
Derivative liabilities, recorded in accrued expenses and other current liabilities
5,069
5,069
—
5,069
—
Derivative liabilities, recorded in deferred credits and other liabilities
Derivative assets, recorded in other current assets
542
542
—
542
—
Derivative assets, recorded in other assets
—
—
—
—
—
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt
$
1,781,351
$
1,834,057
$
—
$
1,834,057
$
—
Derivative liabilities, recorded in accrued expenses and other current assets
9,778
9,778
—
9,778
—
Derivative liabilities, recorded in deferred credits and other liabilities
897
897
—
897
—
Derivative assets and liabilities reported in level 2 include foreign currency and interest rate contracts. See Note 17- Derivative Financial Instruments for additional information about our derivative assets and liabilities.
There are no material non-financial assets or liabilities as of June 26, 2021 or December 31, 2020.
Note 19. Commitments and Contingencies
Litigation – We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates.
Other than the matters described below, there were no proceedings or litigation matters involving the Company or its property as of June 26, 2021 that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period.
Steves & Sons, Inc. vs JELD-WEN, Inc. – We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves and Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (the “Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition.
In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act, and found that JWI breached the supply agreement between the parties (the “Original Action”). The verdict awarded Steves$12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim.
During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals, and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages, and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas (the “Steves Texas Trade Secret Theft Action”). These claims were stayed pending appeal.
On March 13, 2019, the presiding judge entered an Amended Final Judgment Order in the Original Action, awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granting divestiture of
certain assets acquired in the CMI acquisition, subject to appeal. The judgment also conditionally awarded damages in the event the judgment was overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order was overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims were overturned on appeal.
On April 12, 2019, Steves filed a petition requesting an award of its fees and a bill of costs, seeking $28.4 million in attorneys’ fees and $1.7 million in costs in connection with the Original Action. That petition remains pending and subject to further appeal. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019 (the “Pricing Action”). We also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order and going forward through the end of the parties’ current supply agreement (the “Future Pricing Action”). We opposed that request for further relief.
JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which was heard by the Fourth Circuit Court of Appeals (the “Fourth Circuit”) on May 29, 2020. On February 18, 2021, the Fourth Circuit issued its decision on appeal in the Original Action, affirming the Amended Final Judgment Order in part and vacating and remanding in part. The Fourth Circuit vacated the Eastern District of Virginia’s alternative $139.4 million lost-profits award, holding that award was premature because Steves has not suffered the purported injury on which its claim for future lost profits rests. The Fourth Circuit also vacated the Eastern District of Virginia’s judgment for Sam Steves, Edward Steves, and John Pierce on JELD-WEN’s trade secrets claims. The Fourth Circuit affirmed the Eastern District of Virginia’s finding of antitrust injury and its award of $36.5 million in past antitrust damages, which continues to accrue post-judgment interest. It also affirmed the Eastern District of Virginia’s divestiture order, while clarifying that JELD-WEN retains the right to challenge the terms of any divestiture, including whether a sale to any particular buyer will serve the public interest, and made clear that the Eastern District of Virginia may need to revisit its divestiture order if the special master cannot locate a satisfactory buyer. JELD-WEN then filed a motion for rehearing en banc with the Fourth Circuit that was denied on March 22, 2021. The Eastern District of Virginia now has jurisdiction to begin working on the divestiture process, and a special master who has been appointed by the presiding judge overseeing this process.
We continue to believe that Steves’ claims lack merit and Steves is not entitled to the extraordinary remedy of divestiture of certain assets acquired in the CMI acquisition. We believe that multiple pretrial and trial rulings were erroneous and improperly limited the Company’s defenses and that the judgment in accordance with the verdict was improper for several reasons under applicable law. However, following a thorough review, and consistent with our practice, we have concluded at this time that it is in the best interest of the Company and its stakeholders to commence a process for the divestiture of the Company’s Towanda, PA operations and certain related assets. Although the Company will not be seeking Supreme Court review of the Fourth Circuit’s February 18, 2021 decision, the Company retains the legal right to challenge the divestiture process and the final divestiture order. It is not possible at this time to estimate the ultimate impact of any final divestiture, and there can be no guarantee that the divestiture will be consummated.
During the pendency of the Original Action, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the Eastern District of Virginia alleging that we breached the long-term supply agreement between the parties, among other claims, including by incorrectly calculating the allocation of door skins owed to Steves (the “Allocation Action”). Steves sought an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction, and the parties settled the issues underlying the preliminary injunction on April 30, 2020 and reserved the right to appeal the ruling in the Fourth Circuit. The Company believed all the claims lacked merit and moved to dismiss the antitrust and tortious interference claims.
On June 2, 2020, we entered into a settlement agreement with Steves to resolve the Pricing Action, the Future Pricing Action, and the Allocation Action. As a result of the settlement, Steves filed a notice of satisfaction of judgment in the Pricing Action, withdrew its Future Pricing Action with prejudice, and filed a stipulated dismissal with prejudice in the Allocation Action. The Company also withdrew its appeal of the Pricing Action. The parties agreed to bear their own respective attorneys’ fees and costs in these actions. In partial consideration of the settlement, JWI and Steves entered into an amended supply agreement satisfactory to both parties that ends on September 10, 2021. This settlement had no effect on the Original Action between the parties except to agree that certain specific terms of the Amended Final Judgment Order in the Original Action will apply to the amended supply agreement during the pendency of the appeal of the Original Action. Under the Amended Final Judgment Order, if the Original Action remains on appeal as of September 10, 2021, the Company’s supply agreement with Steves will be extended for one year beyond the conclusion of the appeal. The settlement also does not have any effect on the Steves Texas Trade Secret Theft Action, which we remain enjoined from pursuing by the Eastern District of Virginia’s injunction in the Original Action. That injunction is on appeal in the Fourth Circuit, and we expect oral arguments to be scheduled for later in the year or in early 2022.
We continue to believe the claims in the settled actions lacked merit and made no admission of liability in these matters.
Cambridge Retirement System v. JELD-WEN Holding, Inc., et al. – On February 19, 2020, Cambridge Retirement System filed a putative class action lawsuit in the Eastern District of Virginia against the Company, current and former Company executives, and various Onex-related entities alleging violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants and Onex-related entities (“Cambridge”). The lawsuit seeks compensatory damages, equitable relief and an award of attorneys’ fees and costs. On May 8, 2020, the Public Employees Retirement System of Mississippi and the Plumbers and Pipefitters National Pension Fund were named as co-lead plaintiffs and filed an amended complaint on June 22, 2020. We filed a motion to dismiss the amended complaint on July 29, 2020, which was denied on October 26, 2020. On January 19, 2021, the plaintiffs filed a motion for class certification, which we opposed on February 2, 2021. The court granted the plaintiffs’ motion for class certification on March 29, 2021. On April 12, 2021, we filed a petition to seek the Fourth Circuit’s permission to appeal this class certification opinion.
On April 20, 2021, the parties reached an agreement in principle to resolve this securities class action. The agreement contemplates a full release of claims through the date of preliminary court approval of the settlement in exchange for a payment of $39.5 million funded by the Company’s D&O carriers. On April 21, 2021, the parties jointly informed the court of their agreement, and the court stayed all deadlines in the case. As part of the settlement agreement, on April 22, 2021, we withdrew our petition to the Fourth Circuit for its permission to appeal the district court’s class certification opinion. On June 4, 2021, the parties filed their stipulation of dismissal of the action and the plaintiffs’ motion for preliminary approval of the settlement agreement. The Company continues to believe that the plaintiffs’ claims lack merit and has denied any liability or wrongdoing for the claims made against the Company. The settlement agreement remains subject to court approval and other conditions. On July 27, 2021, the Eastern District of Virginia preliminarily approved the settlement agreement and the hearing for final approval is scheduled to be held on November 22, 2021.
On February 2, 2021, Jason Aldridge, on behalf of the Company, filed a derivative action in the U.S. District Court for the District of Delaware against certain current and former executives and directors of the Company, alleging that the individual defendants breached their fiduciary duties by allowing the wrongful acts alleged in the Steves and Cambridge actions, as well as violations of Section 14(a) and 20(a) of the Exchange Act, unjust enrichment, and waste of corporate assets (“Aldridge”). The lawsuit seeks compensatory damages, equitable relief, and an award of attorneys’ fees and costs. The parties sought a stay of the Aldridge action. On April 19, 2021, the court denied the parties’ motion to stay and, instead, ordered the plaintiff to file an amended complaint that complied with court rules or the matter would be dismissed. The plaintiff filed an amended complaint on May 10, 2021, and the Company responded on July 23, 2021.
On June 21, 2021, Shieta Black and the Board of Trustees of the City of Miami General Employees’ & Sanitation Employees’ Retirement Trust, on behalf of the Company, filed a derivative action in the U.S. District Court for the District of Delaware against certain current and former executives and directors of the Company and Onex Corporation, alleging that the defendants breached their fiduciary duties by allowing the wrongful acts alleged in the Steves and Cambridge actions, as well as insider trading, and unjust enrichment (“Black”). The lawsuit seeks compensatory damages, corporate governance reforms, restitution, equitable relief, and an award of attorneys’ fees and costs. The plaintiffs in the Black and Aldridge actions sought to consolidate the lawsuits on July 12, 2021, which was denied by the court on July 14, 2021.
The Company believes the claims in the Aldridge and Black actions lack merit and intends to defend against the actions.
In re Interior Molded Doors Antitrust Litigation – On October 19, 2018, Grubb Lumber Company, on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and one of our competitors in the doors market, Masonite Corporation (“Masonite”), in the Eastern District of Virginia. We subsequently received additional complaints from and on behalf of direct and indirect purchasers of interior molded doors. The suits were consolidated into two separate actions, a Direct Purchaser Action and an Indirect Purchaser Action. The suits allege that Masonite and JELD-WEN violated Section 1 of the Sherman Act, and in the Indirect Purchaser Action, related state law antitrust and consumer protection laws, by engaging in a scheme to artificially raise, fix, maintain, or stabilize the prices of interior molded doors in the United States. The complaints sought ordinary and treble damages, declaratory relief, interest, costs, and attorneys’ fees. The Company believes the claims lack merit and vigorously defended against the actions.On September 18, 2019, the court granted in part and denied in part the defendants’ motions to dismiss the lawsuits, dismissing various state law claims and limiting plaintiffs’ damages claims to a four-year period (from 2014-2018) under the applicable statute of limitations. Together with Masonite, we filed motions to oppose class certification in both the Direct Purchaser and Indirect Purchaser Actions on May 19, 2020.
On August 31, 2020, JELD-WEN and Masonite entered into a settlement agreement to resolve the Direct Purchaser Action. In exchange for a full release of claims through the date of preliminary court approval of the settlement, each defendant originally agreed to pay $28.0 million to the named plaintiffs and the settlement class. On January 27, 2021, the parties to the Direct Purchaser Action revised the settlement agreement to modify certain terms, and each defendant agreed to pay a total of $30.8 million to the named plaintiffs and the settlement class in exchange for a full release of claims through the date of preliminary approval of the revised settlement, which the court granted on February 5, 2021. In addition, on
September 4, 2020, JELD-WEN and Masonite entered into a separate settlement agreement to resolve the Indirect Purchaser Action. Each defendant agreed to pay $9.75 million to the named plaintiffs and the settlement class in exchange for a full release of claims through the execution date of the settlement agreement, and the court has granted preliminary approval of this settlement in the Indirect Purchaser Action. The final fairness hearing in the Direct Purchaser Action was held on June 2, 2021, and the court entered a final approval order and judgment on June 3, 2021. On June 17, 2021, the Company made the settlement payment to the named plaintiffs and the settlement class in the Direct Purchaser Action. The deadline to appeal the entry of the final approval order and judgment was July 7, 2021, and no party or class member filed an appeal. The final fairness hearing in the Indirect Purchaser Action was held on July 26, 2021 and the court issued a final approval order and judgment on July 27, 2021. The Company continues to believe that the plaintiffs’ claims lacked merit and has denied any liability or wrongdoing for the claims made against the Company.
Canadian Antitrust Litigation – On May 15, 2020, Développement Émeraude Inc., on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and Masonite in the Superior Court of the Province of Quebec, Canada, which was served on us on September 18, 2020 (“the Quebec Action”). The putative class consists of any person in Canada who, since October 2012, purchased one or more interior molded doors from us or Masonite. The suit alleges an illegal conspiracy between us and Masonite to agree on prices, the distribution of market shares and/or the production levels of interior molded doors and that the plaintiffs suffered damages in that they were charged and paid higher prices for interior molded doors than they would have had to pay but for the alleged anti-competitive conduct. The plaintiffs are seeking compensatory and punitive damages, attorneys’ fees and costs. On September 9, 2020, Kate O’Leary Swinkels, on behalf of herself and others similarly situated, filed a putative class action against JELD-WEN and Masonite in the Federal Court of Canada, which was served on us on September 29, 2020 (the “Federal Court Action”). The Federal Court Action makes substantially similar allegations to the Quebec Action and the putative class is represented by the same counsel. In February 2021, the plaintiff in the Federal Court Action noticed a proposed Amended Statement of Claim that replaced the named plaintiff, Kate O’Leary Swinkels, with David Regan. The plaintiff has sought a stay of the Quebec Action while the Federal Court Action proceeds. We do not anticipate a hearing on the certification of the Federal Court Action before the middle of 2022. The Company believes both the Quebec Action and the Federal Court Action lack merit and intends to vigorously defend against them.
We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 7 – Accrued Expenses and Other Current Liabilities. While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows.
Self-Insured Risk – We self-insure substantially all of our domestic business liability risks including general liability, product liability, warranty, personal injury, auto liability, workers’ compensation and employee medical benefits. Excess insurance policies from independent insurance companies generally cover exposures between $5.0 million and $200.0 million for domestic product liability risk and exposures between $3.0 million and $200.0 million for auto, general liability, personal injury and workers’ compensation. We have no stop loss insurance covering our self-insured employee medical plan and are responsible for all claims thereunder. We estimate our provision for self-insured losses based upon an evaluation of current claim exposure and historical loss experience. Actual self-insurance losses may vary significantly from these estimates. At June 26, 2021 and December 31, 2020, our accrued liability for self-insured risks was $83.4 million and $81.0 million, respectively.
Indemnifications– At June 26, 2021, we had commitments related to certain representations made in contracts for the purchase or sale of businesses or property. These representations primarily relate to past actions such as responsibility for transfer taxes if they should be claimed, and the adequacy of recorded liabilities, warranty matters, employment benefit plans, income tax matters, or environmental exposures. These guarantees or indemnification responsibilities typically expire within one to three years. We are not aware of any material amounts claimed or expected to be claimed under these indemnities. From time to time and in limited geographic areas, we have entered into agreements for the sale of our products to certain customers that provide additional indemnifications for liabilities arising from construction or product defects. We cannot estimate the potential magnitude of such exposures, but to the extent specific liabilities have been identified related to product sales, liabilities have been provided in the warranty accrual in the accompanying consolidated balance sheets.
Other Financing Arrangements– At times we are required to provide letters of credit, surety bonds, or guarantees to meet various performance, legal, warranty, environmental, workers compensation, licensing, utility, and governmental requirements. Stand-by letters of credit are provided to certain customers and counterparties in the ordinary course of business as credit support for contractual performance guarantees, advanced payments received from customers, and future
funding commitments. The stated values of these letters of credit agreements, surety bonds, and guarantees were $118.3 million and $122.7 million at June 26, 2021 and December 31, 2020, respectively.
Environmental Contingencies – We periodically incur environmental liabilities associated with remediating our current and former manufacturing sites as well as penalties for not complying with environmental rules and regulations. We record a liability for remediation costs when it is probable that we will be responsible for such costs and the costs can be reasonably estimated. These environmental liabilities are estimated based on current available facts and current laws and regulations. Accordingly, it is likely that adjustments to the estimated liabilities will be necessary as additional information becomes available. Short-term environmental liabilities and settlements are recorded in accrued expenses in the accompanying consolidated balance sheets and totaled $0.7 million at June 26, 2021 and December 31, 2020. Long-term environmental liabilities are recorded in deferred credits and other liabilities in the accompanying consolidated balance sheets and totaled $8.3 million at June 26, 2021 and December 31, 2020.
Everett, Washington WADOE Action –In 2008, we entered into an Agreed Order with the WADOE to assess historic environmental contamination and remediation feasibility at our former manufacturing site in Everett, Washington. As part of this agreement, we also agreed to develop a CAP, arising from the feasibility assessment, and in December 2020, we submitted to the WADOE a draft feasibility assessment which we considered substantially complete containing remedial alternatives ranging from $8.3 million to $57.0 million. In January 2021, we provided the WADOE with a revised draft of our feasibility assessment and received comments from the WADOE in February 2021. We responded to the WADOE’s comments and submitted our revised draft of our feasibility assessment to the WADOE in April 2021. On June 3, 2021, the WADOE submitted the draft final feasibility assessment for a 30-day public comment period. On June 7, 2021, the WADOE named the Port of Everett as a PLP with respect to this matter, and the Port of Everett requested an extension of the public comment period. The WADOE agreed to extend the public comment period until August 5, 2021. The final feasibility assessment incorporating public comments is due shortly after the expiration of the public comment period. Currently, we expect to deliver a draft CAP to the WADOE in October 2021 which the WADOE has sixty days to review and provide comments. At that time, the WADOE will release the documents to the public for a 30-day comment period. Once the public comment period has expired and any comments incorporated, the WADOE will select the remedial actions we will be required to perform, and a final CAP will be developed and delivered to the WADOE 15 days thereafter. While we have made provisions in our financial statements within the range of possible outcomes for this matter, it is unclear at this time which remedial actions we will be required to undertake, the cost thereof, or the allocation of the costs to the identified PLPs. As a result, the cost of the final CAP could vary materially from our provisions and have a material impact on our statement of operations and statement of cash flows.
Towanda, Pennsylvania Consent Order –In December 2020, we entered into a COA with the PaDEP to remove a pile of wood fiber waste from our site in Towanda, Pennsylvania, which we acquired in connection with our acquisition of CMI in 2013, by using it as fuel for a boiler at that site. The COA replaced a 2018 Consent Decree between PaDEP and us. Under the COA, we are required to achieve certain periodic removal objectives and ultimately remove the entire pile by August 31, 2025. There are currently $2.3 million in bonds posted in connection with these obligations. If we are unable to remove this pile by August 31, 2025, then the bonds will be forfeited, and we may be subject to penalties by PaDEP. We currently anticipate meeting all applicable removal deadlines; however, if our operations at this site decrease and we burn less fuel than currently anticipated, we may not be able to meet such deadlines.
U.S. Defined Benefit Pension Plan – Certain U.S. hourly employees participate in our defined benefit pension plan. The plan is not open to new employees. Pension benefit (income) expense, as recorded in the accompanying unaudited consolidated statements of operations, is determined by using spot rate assumptions made on January 1 of each year as summarized below:
Three Months Ended
Six Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
June 26, 2021
June 27, 2020
Components of pension benefit expense - U.S. benefit plan:
Administrative cost
$
750
$
300
$
1,500
$
1,550
Interest cost
2,225
2,375
4,450
6,100
Expected return on plan assets
(5,575)
(6,300)
(11,150)
(10,950)
Amortization of net actuarial pension loss
2,325
1,225
4,650
3,450
Pension benefit (income) expense
$
(275)
$
(2,400)
$
(550)
$
150
We have no required contributions for the U.S. defined benefit pension plan (the “Plan”) in 2021. During the six months ended June 27, 2020, we made required contributions to the Plan of $1.6 million. We did not make voluntary contributions during any of the periods presented above.
During the three months ended June 27, 2020, we elected to utilize the alternative method when calculating the Pension Benefit Guarantee Corporation premiums for 2020 and the succeeding four years, rather than the standard method utilized during the previous five years, resulting in a reduction to pension benefit expenses.
Cash paid for amounts included in the measurement of lease liabilities
$
29,847
$
28,199
Non-cash Investing Activities:
Property, equipment and intangibles purchased in accounts payable
$
5,557
$
4,517
Property, equipment and intangibles purchased with debt
3,421
7,913
Cash Financing Activities:
Proceeds from issuance of new debt
$
—
$
250,000
Borrowings on long-term debt
258
100,353
Payments of long-term debt
(54,912)
(111,921)
Payments of debt issuance and extinguishment costs, including underwriting fees
—
(4,136)
Change in long-term debt
$
(54,654)
$
234,296
Cash paid for amounts included in the measurement of finance lease liabilities
$
1,164
$
712
Non-cash Financing Activities:
Debt issuance costs deducted from long-term debt borrowings in accounts payable
$
—
$
697
Prepaid insurance funded through short-term debt borrowings
2,570
1,691
Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities
171
2
Accounts payable converted to installment notes
69
914
Other Supplemental Cash Flow Information:
Cash taxes paid, net of refunds
$
24,044
$
10,888
Cash interest paid
35,623
28,620
We have revised prior year borrowings and payments of long-term debt to reflect gross activity relating to our ABL Facility. There is no impact to the disclosed Change in long-term debt amount for any previously reported period.
Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
In addition to historical information, this 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which are subject to the “safe harbor” created by those sections. All statements, other than statements of historical facts, included in this 10-Q are forward-looking statements. You can generally identify forward-looking statements by our use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “seek,” or “should,” or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, including the impact of COVID-19, the outcome of legal proceeding, or future events or performance contained under the heading Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations are forward-looking statements.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the headings Item 1A- Risk Factors in our annual report on Form 10-K and Item 1A – Risk Factors and Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations in this 10-Q may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include:
•negative trends in overall business, financial market and economic conditions, and/or activity levels in our end markets;
•our highly competitive business environment;
•failure to timely identify or effectively respond to consumer needs, expectations, or trends;
•failure to maintain the performance, reliability, quality, and service standards required by our customers;
•failure to successfully implement our strategic initiatives, including JEM;
•acquisitions or investments in other businesses that may not be successful;
•adverse outcome of pending or future litigation;
•declines in our relationships with and/or consolidation of our key customers;
•increases in interest rates and reduced availability of financing for the purchase of new homes and home construction and improvements;
•fluctuations in the prices of raw materials used to manufacture our products;
•delays or interruptions in the delivery of raw materials or finished goods;
•seasonal business with varying revenue and profit;
•changes in weather patterns;
•political, regulatory, economic, and other risks, including pandemics, such as COVID-19, that arise from operating a multinational business;
•exchange rate fluctuations;
•disruptions in our operations;
•manufacturing realignments and cost savings programs resulting in a decrease in short-term earnings;
•our Enterprise Resource Planning system that we are currently implementing proving ineffective;
•security breaches and other cybersecurity incidents;
•increases in labor costs, potential labor disputes, and work stoppages at our facilities;
•changes in building codes that could increase the cost of our products or lower the demand for our windows and doors;
•compliance costs and liabilities under environmental, health, and safety laws and regulations;
•compliance costs with respect to legislative and regulatory proposals to restrict emission of GHGs;
•lack of transparency, threat of fraud, public sector corruption, and other forms of criminal activity involving government officials;
•product liability claims, product recalls, or warranty claims;
•inability to protect our intellectual property;
•loss of key officers or employees;
•pension plan obligations;
•our current level of indebtedness;
•risks associated with any material weaknesses in our internal controls;
•the extent of Onex’s control of us; and
•other risks and uncertainties, including those listed under Item 1A- Risk Factors in our 10-K.
Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this 10-Q are not guarantees of future performance and our actual results of operations, financial condition, and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained herein. In addition, even if our results of operations, financial condition, and liquidity, and events in the industry in which we operate, are consistent with the forward-looking statements contained in this 10-Q, they may not be predictive of results or developments in future periods.
Any forward-looking statement in this 10-Q speaks only as of the date of this 10-Q or as of the date such statement was made. We do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Unless the context requires otherwise, references in this 10-Q to “we,” “us,” “our,” “the Company,” or “JELD-WEN” mean JELD-WEN Holding, Inc., together with our consolidated subsidiaries where the context requires, including our wholly owned subsidiary JWI.
This discussion should be read in conjunction with our historical financial statements and related notes thereto and the other disclosures contained elsewhere in this 10-Q. The results of operations for the periods reflected herein are not necessarily indicative of results that may be expected for future periods, and our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including but not limited to those listed under Item 1A- Risk Factors in our annual report on Form 10-K and Item 1A – Risk Factors in this 10-Q and included elsewhere in this 10-Q.
This MD&A is a supplement to our financial statements and notes thereto included elsewhere in this 10-Q and is provided to enhance your understanding of our results of operations and financial condition. Our discussion of results of operations is presented in millions throughout the MD&A and due to rounding may not sum or calculate precisely to the totals and percentages provided in the tables. Our MD&A is organized as follows:
•Overview and Background. This section provides a general description of our Company and reportable segments, business and industry trends, our key business strategies and background information on other matters discussed in this MD&A.
•Consolidated Results of Operations and Operating Results by Business Segment. This section provides our analysis and outlook for the significant line items on our consolidated statements of operations, as well as other information that we deem meaningful to an understanding of our results of operations on both a consolidated basis and a business segment basis.
•Liquidity and Capital Resources. This section contains an overview of our financing arrangements and provides an analysis of trends and uncertainties affecting liquidity, cash requirements for our business, and sources and uses of our cash.
•Critical Accounting Policies and Estimates. This section discusses the accounting policies that we consider important to the evaluation and reporting of our financial condition and results of operations, and whose application requires significant judgments or a complex estimation process.
We are a leading global provider of windows, doors, wall systems, and building products. We design, produce, and distribute an extensive range of interior and exterior doors, wood, vinyl, and aluminum windows, and related products for use in the new construction, R&R of residential homes, and, to a lesser extent, non-residential buildings.
We operate manufacturing and distribution facilities in 19 countries, located primarily in North America, Europe, and Australia. For many product lines, our manufacturing processes are vertically integrated, enhancing our range of capabilities, our ability to innovate, and our quality control as well as providing supply chain, transportation, and working capital savings.
Business Segments
Our business is organized in geographic regions to ensure integration across operations serving common end markets and customers. We have three reportable segments: North America, Europe, and Australasia. Financial information related to our business segments can be found in Note 11 – Segment Information of our financial statements included elsewhere in this 10-Q.
Significant Developments
In March 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. In the following weeks, global restrictions, including stay at home and similar orders, were implemented in a significant number of countries in which we operate. We made, and continue to make, changes to our operations to ensure proper measures are in place for the health and safety of our employees and to satisfy the needs of our customers. We continue to experience intermittent closures of certain manufacturing facilities due to local and governmental mandates, most recently in our Australasia segment and portions of our North America segment. We continue to experience increased demand for our products in both residential and remodel channels due to the low residential housing supply, low interest rates, and consumers’ focus on their homes. As a result of the increased demand for our products, we have and may continue to see increased inflation in our supply chain, including raw materials and freight charges, as well as the availability of labor due to the pandemic.
Results of Operations
The tables in this section summarize key components of our results of operations for the periods indicated, both in U.S. dollars and as a percentage of our net revenues. Certain percentages presented in this section have been rounded to the nearest whole number. Accordingly, totals may not equal the sum of the line items in the tables below. We define core revenue as revenue excluding the impact of foreign exchange and acquisitions completed in the last twelve months.
Comparison of the Three Months Ended June 26, 2021 to the Three Months Ended June 27, 2020
Net Revenues – Net revenues increased $253.5 million, or 25.5%, to $1,245.8 million in the three months ended June 26, 2021 from $992.3 million in the three months ended June 27, 2020. The increase was due to an improvement in core revenues of 19%, consisting of favorable volume/mix of 13% and a 6% benefit from pricing, as well as a 6% positive impact from foreign exchange.
Gross Margin – Gross margin increased $73.2 million, or 33.5%, to $291.9 million in the three months ended June 26, 2021 from $218.7 million in the three months ended June 27, 2020. Gross margin as a percentage of net revenues was 23.4% in the three months ended June 26, 2021 and 22.0% in the three months ended June 27, 2020. The increase in gross margin percentage was due to favorable volume/mix, improved pricing, lower material usage and sourcing savings, partially offset by the impact of inflation on material costs, freight, and labor compensation in the current period.
SG&A Expense – SG&A expense increased $22.4 million, or 13.4%, to $188.7 million in the three months ended June 26, 2021 from $166.3 million in the three months ended June 27, 2020. SG&A expense as a percentage of net revenues decreased to 15.1% in the three months ended June 26, 2021 from 16.8% in the three months ended June 27, 2020. The increase in SG&A expense was primarily due to the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits, and the impact of inflation on compensation in the current period, partially offset by reduced legal and professional fees.
Impairment and Restructuring Charges – Impairment and restructuring charges decreased $1.1 million, or 49.5%, to $1.1 million in the three months ended June 26, 2021 from $2.3 million in the three months ended June 27, 2020. The decrease in impairment and restructuring charges was primarily due to reduced restructuring efforts, primarily in North America, during the second quarter of 2021 as compared to the second quarter of 2020.
Interest Expense, Net – Interest expense, net decreased $0.2 million, or 1.1%, to $18.9 million in the three months ended June 26, 2021 from $19.1 million in the three months ended June 27, 2020. The decrease was primarily due to lower interest rates applicable to variable rate debt.
Other Expense (Income) – Other expense (income) changed $2.7 million to expense of $0.2 million in the three months ended June 26, 2021 from income of $2.5 million in the three months ended June 27, 2020. Other expense in the three months ended June 26, 2021 consisted primarily of a loss on sale or disposal of property and equipment of $1.3 million and foreign currency losses of $0.3 million, partially offset by governmental pandemic assistance reimbursements and government grants. Other income in the three months ended June 27, 2020 primarily consisted of $5.9 million for cash received as a result of governmental pandemic assistance reimbursements relating to COVID-19 and a reduction in pension expenses of $2.2 million, partially offset by foreign currency losses of $6.3 million.
Income Taxes – Income tax expense increased $12.0 million, or 114.9%, to $22.4 million in the three months ended June 26, 2021 from $10.4 million in the three months ended June 27, 2020. The effective tax rate in the three months ended June 26, 2021 was 26.9% compared to 31.1% in the three months ended June 27, 2020. The increase in tax expense of $12.0 million in the current period was primarily driven by an increase in income before taxes of $49.6 million and a decrease in discrete tax impacts in the current period, compared to the three months ended June 27, 2020.
Comparison of the Six Months Ended June 26, 2021 to the Six Months Ended June 27, 2020
Six Months Ended
June 26, 2021
June 27, 2020
(amounts in thousands)
% of Net Revenues
% of Net Revenues
Net revenues
$
2,338,198
100.0
%
$
1,971,533
100.0
%
Cost of sales
1,810,342
77.4
%
1,558,493
79.0
%
Gross margin
527,856
22.6
%
413,040
21.0
%
Selling, general and administrative
380,245
16.3
%
338,911
17.2
%
Impairment and restructuring charges
2,072
0.1
%
8,811
0.4
%
Operating income
145,539
6.2
%
65,318
3.3
%
Interest expense, net
37,315
1.6
%
35,680
1.8
%
Other income
(10,689)
(0.5)
%
(4,829)
(0.2)
%
Income before taxes
118,913
5.1
%
34,467
1.7
%
Income tax expense
32,718
1.4
%
11,600
0.6
%
Net income
$
86,195
3.7
%
$
22,867
1.2
%
Consolidated Results
Net Revenues – Net revenues increased $366.7 million, or 18.6%, to $2,338.2 million in the six months ended June 26, 2021 from $1,971.5 million in the six months ended June 27, 2020. The increase was due to an improvement in core revenues of 13%, consisting of favorable volume/mix of 8% and a 5% benefit from pricing, as well as a 6% positive impact from foreign exchange.
Gross Margin – Gross margin increased $114.8 million, or 27.8%, to $527.9 million in the six months ended June 26, 2021 from $413.0 million in the six months ended June 27, 2020. Gross margin as a percentage of net revenues was 22.6% in the six months ended June 26, 2021 and 21.0% in the six months ended June 27, 2020. The increase in gross margin percentage was due to favorable volume/mix, improved pricing, lower material and labor usage and sourcing savings, partially offset by the impact of inflation on material costs, freight, and labor compensation in the current period.
SG&A Expense – SG&A expense increased $41.3 million, or 12.2%, to $380.2 million in the six months ended June 26, 2021 from $338.9 million in the six months ended June 27, 2020. The increase in SG&A expense was primarily due to the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits, the impact of inflation on compensation in the current period, and estimated variable compensation, partially offset by reduced legal and professional fees.
Impairment and Restructuring Charges – Impairment and restructuring charges decreased $6.7 million, or 76.5%, to $2.1 million in the six months ended June 26, 2021 from $8.8 million in the six months ended June 27, 2020. Charges incurred in 2021 primarily relate to ongoing restructuring projects within our Europe segment. Charges incurred in 2020 primarily related to severance charges for ongoing restructuring projects across all segments as well as impairment charges primarily related to capitalized costs of certain ERP modules due to delays in implementation and uncertainty of their future use. For more information, refer to Note 15 – Impairment and Restructuring Charges to our consolidated financial statements included in this 10-Q.
Interest Expense, Net – Interest expense, net, increased $1.6 million, or 4.6%, to $37.3 million in the six months ended June 26, 2021 from $35.7 million in the six months ended June 27, 2020. The increase was primarily due to interest on our Senior Secured Notes issued in May 2020, partially offset by not having any amount outstanding under on our ABL Facility and a lower cost of borrowing on our Term Loan Facility during 2021.
Other Income – Other income increased $5.9 million, or 121.4%, to $10.7 million in the six months ended June 26, 2021 from $4.8 million in the six months ended June 27, 2020. The other income in the six months ended June 26, 2021 primarily consisted of foreign currency gains of $8.9 million and governmental pandemic assistance reimbursements and government grants. Other income in the six months ended June 27, 2020 primarily consisted of $5.9 million for cash received as a result of governmental pandemic assistance reimbursements relating to COVID-19, and a gain on sale of property and equipment of $2.4 million, partially offset by foreign currency losses of $4.1 million.
Income Taxes – Income tax expense increased $21.1 million, or 182.1%, to $32.7 million in the six months ended June 26, 2021 from $11.6 million in the six months ended June 27, 2020. The effective tax rate in the six months ended June 26, 2021 was 27.5% compared to 33.7% in the six months ended June 27, 2020. The increase in income tax expense in the six months ended June
26, 2021 was primarily due to an increase in income before taxes of $84.4 million and a decrease in discrete tax impacts in the current period, compared to the six months ended June 27, 2020.
Segment Results
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC 280-10 - Segment Reporting. We have determined that we have three reportable segments, organized and managed principally by geographic region. Our reportable segments are North America, Europe, and Australasia. We report all other business activities in Corporate and unallocated costs. We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing. For additional information on segment Adjusted EBITDA, see Note 11 – Segment Information to our consolidated financial statements included in this 10-Q.
Comparison of the Three Months Ended June 26, 2021 to the Three Months Ended June 27, 2020
Three Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
Net revenues from external customers
% Variance
North America
$
740,128
$
608,113
21.7
%
Europe
349,747
261,524
33.7
%
Australasia
155,940
122,709
27.1
%
Total Consolidated
$
1,245,815
$
992,346
25.5
%
Percentage of total consolidated net revenues
North America
59.4
%
61.3
%
Europe
28.1
%
26.3
%
Australasia
12.5
%
12.4
%
Total Consolidated
100.0
%
100.0
%
Adjusted EBITDA(1)
North America
$
115,320
$
91,115
26.6
%
Europe
39,784
28,354
40.3
%
Australasia
17,995
15,235
18.1
%
Corporate and unallocated costs
(24,857)
(8,985)
176.6
%
Total Consolidated
$
148,242
$
125,719
17.9
%
Adjusted EBITDA as a percentage of segment net revenues
North America
15.6
%
15.0
%
Europe
11.4
%
10.8
%
Australasia
11.5
%
12.4
%
Total Consolidated
11.9
%
12.7
%
(1)Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA, see Note 11 –Segment Information in our unaudited interim consolidated financial statements.
North America
Net revenues in North America increased $132.0 million, or 21.7%, to $740.1 million in the three months ended June 26, 2021 from $608.1 million in the three months ended June 27, 2020. The increase was primarily due to an increase in core revenues of 21%, consisting of favorable volume/mix of 13% and a 8% benefit from pricing.
Adjusted EBITDA in North America increased $24.2 million, or 26.6%, to $115.3 million in the three months ended June 26, 2021 from $91.1 million in the three months ended June 27, 2020. The increase was primarily due to favorable pricing and volume/mix, partially offset by the effect of inflation on material costs, freight, and labor compensation and the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits.
Net revenues in Europe increased $88.2 million, or 33.7%, to $349.7 million in the three months ended June 26, 2021 from $261.5 million in the three months ended June 27, 2020. The increase was due to an increase in core revenues of 21%, consisting of favorable volume/mix of 18% and a 3% benefit from pricing, and a 13% positive impact from foreign exchange.
Adjusted EBITDA in Europe increased $11.4 million, or 40.3%, to $39.8 million in the three months ended June 26, 2021 from $28.4 million in the three months ended June 27, 2020. The increase was primarily due to improved volume/mix and pricing, lower material usage, and improved labor efficiency, partially offset by the impact of inflation on material costs and labor compensation in the current period and the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits, and governmental pandemic assistance provided in 2020.
Australasia
Net revenues in Australasia increased $33.2 million, or 27.1%, to $155.9 million in the three months ended June 26, 2021 from $122.7 million in the three months ended June 27, 2020. The increase was due to a 18% positive impact from foreign exchange and an increase in core revenues of 9%, consisting of favorable volume/mix of 8% and a 1% benefit from pricing.
Adjusted EBITDA in Australasia increased $2.8 million, or 18.1%, to $18.0 million in the three months ended June 26, 2021 from $15.2 million in the three months ended June 27, 2020. The increase was primarily due to improved volume/mix and lower material usage.
Corporate and unallocated costs
Adjusted EBITDA in our corporate and unallocated costs grouping decreased $15.9 million, or 176.6%, to ($24.9) million in the three months ended June 26, 2021 from ($9.0) million in the three months ended June 27, 2020. The decrease in Adjusted EBITDA was primarily due to the non-recurrence of certain cost savings measures implemented in 2020 in response to COVID-19, primarily relating to salary and benefit expenses, and increases in unallocated insurance costs.
Comparison of the Six Months Ended June 26, 2021 to the Six Months Ended June 27, 2020
Six Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
Net revenues from external customers
% Variance
North America
$
1,379,743
$
1,194,849
15.5
%
Europe
670,262
543,017
23.4
%
Australasia
288,193
233,667
23.3
%
Total Consolidated
$
2,338,198
$
1,971,533
18.6
%
Percentage of total consolidated net revenues
North America
59.0
%
60.6
%
Europe
28.7
%
27.5
%
Australasia
12.3
%
11.9
%
Total Consolidated
100.0
%
100.0
%
Adjusted EBITDA(1)
North America
$
195,113
$
140,105
39.3
%
Europe
68,578
51,680
32.7
%
Australasia
31,194
23,960
30.2
%
Corporate and unallocated costs
(48,732)
(15,518)
214.0
%
Total Consolidated
$
246,153
$
200,227
22.9
%
Adjusted EBITDA as a percentage of segment net revenues
North America
14.1
%
11.7
%
Europe
10.2
%
9.5
%
Australasia
10.8
%
10.3
%
Total Consolidated
10.5
%
10.2
%
(1)Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA, see Note 11 –Segment Information in our consolidated financial statements.
Net revenues in North America increased $184.9 million, or 15.5%, to $1,379.7 million in the six months ended June 26, 2021 from $1,194.8 million in the six months ended June 27, 2020. The increase was primarily due to an increase in core revenues of 15%, consisting of favorable volume/mix of 8% and a 7% benefit from pricing.
Adjusted EBITDA in North America increased $55.0 million, or 39.3%, to $195.1 million in the six months ended June 26, 2021 from $140.1 million in the six month ended June 27, 2020. The increase was due to favorable pricing, lower material costs, sourcing savings, and improved labor efficiency, partially offset by the impact of inflation on material costs, freight, and labor compensation in the current period, estimated variable compensation, and the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits.
Europe
Net revenues in Europe increased $127.2 million, or 23.4%, to $670.3 million in the six months ended June 26, 2021 from $543.0 million in the six months ended June 27, 2020. The increase was primarily due to favorable foreign exchange impacts of 12% and an increase in core revenue of 11%, consisting of favorable volume/mix of 9% and a 2% benefit from pricing.
Adjusted EBITDA in Europe increased $16.9 million, or 32.7%, to $68.6 million in the six months ended June 26, 2021 from $51.7 million in the six months ended June 27, 2020. The increase was primarily due to improved volume/mix and pricing, lower material usage, and improved labor efficiency, partially offset by the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits, and governmental pandemic assistance provided in 2020.
Australasia
Net revenues in Australasia increased $54.5 million, or 23.3%, to $288.2 million in the six months ended June 26, 2021 from $233.7 million in the six months ended June 27, 2020. The increase was primarily due to favorable foreign exchange impacts of 18% and an increase in core revenues of 6%, consisting of favorable volume/mix of 5% and a 1% benefit from pricing.
Adjusted EBITDA in Australasia increased $7.2 million, or 30.2%, to $31.2 million in the six months ended June 26, 2021 from $24.0 million in the six months ended June 27, 2020. The increase was primarily due to improved volume/mix and lower material usage, partially by the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits.
Corporate and unallocated costs
Adjusted EBITDA in our corporate and unallocated costs grouping decreased $33.2 million, or 214.0%, to ($48.7) million six months ended June 26, 2021 from ($15.5) million in the six months ended June 27, 2020. The decrease in Adjusted EBITDA was primarily due to the non-recurrence of certain savings from cost reduction measures implemented in 2020 in response to COVID-19, primarily related to salary and benefits, and increases in unallocated insurance costs.
Liquidity and Capital Resources
Overview
We have historically funded our operations through a combination of cash from operations, draws on our revolving credit facilities, and the issuance of non-revolving debt such as our Term Loan Facility, Senior Notes, and Senior Secured Notes. Working capital, which we define as accounts receivable plus inventory less accounts payable, fluctuates throughout the year and is affected by the seasonality of sales of our products, customer payment patterns, and the translation of the balance sheets of our foreign operations into the U.S. dollar. Typically, working capital increases at the end of the first quarter and beginning of the second quarter in conjunction with, and in preparation for, the peak season for home construction and remodeling in our North America and Europe segments, which represent the substantial majority of our revenues, and decreases starting in the fourth quarter as inventory levels and accounts receivable decline. Inventories fluctuate for raw materials with long delivery lead times, such as steel, as we work through prior shipments and take delivery of new orders.
As of June 26, 2021, we had total liquidity (a non-GAAP measure) of $1,022.0 million, consisting of $618.3 million in unrestricted cash, $363.6 million available for borrowing under the ABL Facility, and AUD 52.9 million ($40.1 million) available for borrowing under the Australia Senior Secured Credit Facility (See Note 9 – Long-Term Debt to our consolidated financial statements for additional details regarding amendments made to the ABL Facility in July 2021), compared to total liquidity of $1,121.5 million as of December 31, 2020. The decrease in total liquidity was primarily due to cash utilized for share repurchases, capital expenditures, and repayments of long-term debt, partially offset by the increase in earnings.
As of June 26, 2021, our cash balances, including $0.9 million of restricted cash, consisted of $323.4 million in the U.S. and $295.8 million in non-U.S. subsidiaries. Based on our current level of operations, the seasonality of our business and anticipated growth, we believe that cash provided by operations and other sources of liquidity, including cash, cash equivalents and borrowings under our revolving credit facilities, will provide adequate liquidity for ongoing operations, planned capital expenditures and other investments, and debt service requirements for at least the next twelve months.
We may, from time to time, refinance, reprice, extend, retire or otherwise modify our outstanding debt to lower our interest payments, reduce our debt, or otherwise improve our financial position. These actions may include repricing amendments, extensions, and/or opportunistic refinancing of debt. The amount of debt that may be refinanced, repriced, extended, retired, or otherwise modified, if any, will depend on market conditions, trading levels of our debt, our cash position, compliance with debt covenants, and other considerations. Our affiliates may also purchase our debt from time to time, through open market purchases or other transactions. In such cases, our debt may not be retired, in which case we would continue to pay interest in accordance with the terms of the debt, and we would continue to reflect the debt as outstanding in our consolidated balance sheets.
Based on hypothetical variable rate debt that would have resulted from drawing each revolving credit facility up to the full commitment amount, a 1.0% decrease in interest rates would have reduced our interest expense by $0.6 million in the six months ended June 26, 2021. A 1.0% increase in interest rates would have increased our interest expense by $3.3 million in the same period. The impact of a hypothetical decrease would have been partially mitigated by interest rate floors that apply to certain of our debt agreements.
Borrowings and Refinancings
On July 28, 2021, we refinanced our existing Term Loan Facility and ABL Facility by issuing $550.0 million aggregate principal amount in replacement term loans under the Term Loan Facility and adding $100.0 million in potential additional revolving loan capacity to our ABL Facility. See Note 9 –Long-Term Debt to our consolidated financial statements for additional details.
In the fourth quarter of 2020, we began to include the accounts receivable and inventory balances of certain recently acquired U.S. businesses in determining our borrowing base on our U.S. ABL Facility, which increased our availability.
In May 2020, we issued $250.0 million of Senior Secured Notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility with the remainder to be used for general corporate purposes. In addition, we amended our Australia Senior Credit Facility to add AUD 30.0 million of additional revolving loan capacity.
As of June 26, 2021, we were in compliance with the terms of all of our Credit Facilities and the indentures governing the Senior Notes and Senior Secured Notes.
Our results have been and will continue to be impacted by substantial changes in our net interest expense throughout the periods presented and into the future. See Note 9 – Long-Term Debt to our consolidated financial statements for additional details.
Cash Flows
The following table summarizes the changes to our cash flows for the periods presented:
Six Months Ended
(amounts in thousands)
June 26, 2021
June 27, 2020
Cash provided by (used in):
Operating activities
$
40,741
$
38,315
Investing activities
(41,476)
(38,013)
Financing activities
(110,327)
228,443
Effect of changes in exchange rates on cash and cash equivalents
(6,310)
(184)
Net change in cash and cash equivalents
$
(117,372)
$
228,561
Cash Flow from Operations
Net cash provided by operating activities increased $2.4 million to $40.7 million in the six months ended June 26, 2021 from $38.3 million in the six months ended June 27, 2020. The increase in cash provided by operating activities was due primarily to increased earnings, partially offset by increased cash taxes, cash paid for interest, and legal settlements.
Net cash used in investing activities increased $3.5 million to $41.5 million in the six months ended June 26, 2021 from $38.0 million in the six months ended June 27, 2020 primarily due to a reduction in proceeds from the sale of property and equipment, partially offset by a decrease in capital expenditures.
Cash Flow from Financing Activities
Net cash used in financing activities was $110.3 million in the six months ended June 26, 2021 and consisted primarily of repurchases of our Common Stock of $56.9 million and net debt repayments of $54.7 million.
Net cash provided by financing activities was $228.4 million in the six months ended June 27, 2020 and consisted primarily of net borrowings of $234.3 million, partially offset by repurchases of our Common Stock of $5.0 million.
Critical Accounting Policies and Estimates
Management’s Discussion and Analysis of Results of Operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with those accounting principles requires management to use judgments in making estimates and assumptions based on the relevant information available at the end of each period. These estimates and assumptions may have a significant effect on reported amounts of assets and liabilities, revenue and expenses, as well as the disclosure of contingent assets and liabilities because they result primarily from the need to make estimates and assumptions on matters that are inherently uncertain. Actual results may differ from estimates.
Our significant accounting policies are described in Note 1 – Summary of Significant Accounting Policies to the consolidated financial statements presented in our 10-K. Our critical accounting policies and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the 10-K. Our significant and critical accounting policies have not changed significantly since our 10-K was filed.
Holding Company Status
We are a holding company that conducts all of our operations through subsidiaries. The majority of our operating income is derived from JWI, our main operating subsidiary. Consequently, we rely on dividends or advances from our subsidiaries. The ability of our subsidiaries to pay dividends to us is subject to applicable local law and may be limited due to the terms of other contractual arrangements, including our Credit Facilities, Senior Notes, and Senior Secured Notes.
The Australia Senior Secured Credit Facility also contains restrictions on dividends that limit the amount of cash that the obligors under these facilities can distribute to JWI. Obligors under the Australia Senior Secured Credit Facility may pay dividends only to the extent they do not exceed 80% of after tax net profits (with a one-year carryforward of unused amounts) and only while no default is continuing under such agreement. For further information regarding the Australia Senior Secured Credit Facility, see Note 9 – Long-Term Debt in our consolidated financial statements.
The amount of our consolidated net assets that were available to be distributed under our credit facilities as of June 26, 2021 was $733.9 million.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.
Item 3 - Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various types of market risks, including the effects of adverse fluctuations in foreign currency exchange rates, adverse changes in interest rates, and adverse movements in commodity prices for products we use in our manufacturing. To reduce our exposure to these risks, we maintain risk management controls and policies to monitor these risks and take appropriate actions to attempt to mitigate such forms of market risk. Our market risks have not changed significantly from those disclosed in the 10-K.
The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), which are designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act, including this Report, are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by the Company under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer (“CEO”) and principal financial officer (“CFO”), as appropriate to allow timely decisions regarding required disclosure.
The Company’s management, including the Company’s CEO and CFO, conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report and, based on that evaluation, the CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of June 26, 2021.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s most recently completed quarter ended June 26, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Information relating to this item is included within Note 19 – Commitments and Contingencies of our financial statements included elsewhere in this 10-Q.
Item 1A - Risk Factors
There have been no updates to the risk factors previously disclosed in “Part I, Item 1A-Risk Factors” in our 10-K.
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds
A summary of our repurchases of Common Stock during the second quarter of 2021 is as follows (in thousands, except share and per share amounts):
(a)
(b)
(c)
(d)
Period
Total Number of Shares (or Units) Purchased
Average Price Paid Per Share (or Unit) 1
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs
Maximum Number (or Approximate Dollar Value) of Shares (or Units) That May Yet Be Purchased Under The Plans or Programs 2
March 28, 2021 - April 24, 2021
—
$—
—
$146,857
April 25, 2021 - May 22, 2021
1,062,800
$28.72
1,062,800
$116,334
May 23, 2021 - June 26, 2021
114,957
$28.09
114,957
$113,105
Total
1,177,757
$28.66
1,177,757
1 Average price paid per share includes costs associated with the repurchases.
2 On November 4, 2019, the Board of Directors increased in the amount remaining under the existing share repurchase authorization to $175.0 million with no expiration date and on July 27, 2021, the Board of Directors increased the remaining authorization to a total of $400.0 million with no expiration date.
Item 5 - Other Information
Amendment to Term Loan Facility
On July 28, 2021, we amended the Term Loan Facility to, among other things, extend the maturity date from December 2024 to July 2028 and provide additional covenant flexibility. Pursuant to the amendment, certain existing and new lenders advanced $550.0 million of replacement term loans, the proceeds of which were used to prepay in full the amount outstanding under the existing term loans. The replacement term loans bear interest at LIBOR (subject to a floor of 0.00%) plus a margin of 2.00% to 2.25% depending on JWI’s corporate credit rating, as further described in the amendment. In addition, the amendment also modifies certain other terms and provisions of the Term Loan Facility. Voluntary prepayments of the replacement term loans are permitted at any time, in certain minimum principal amounts, but are subject to a 1.00% premium during the first six months.
The foregoing description of amendment to the Term Loan Facility does not purport to be complete and is qualified in its entirety by
reference to the full text of the amendment. A copy of the amendment is attached as Exhibit 10.2 to this Form 10-Q and is
On July 28, 2021, we amended the ABL Facility to, among other things, extend the maturity date from December 2022 to July 2026, increase the aggregate commitment to $500.0 million, reduce the interest rate applicable to the loans thereunder, provide additional covenant flexibility, and conform certain terms and provisions to the Term Loan Facility. Pursuant to the amendment, the amount allocated to U.S. borrowers was increased to $465.0 million. The amount that could be allocated to Canadian borrowers was maintained at $35.0 million. Borrowings under the ABL Facility bear, at the borrower’s option, interest at either a base rate plus a margin of 0.25% to 0.50% depending on excess availability or LIBOR plus a margin of 1.25% to 1.50% depending on excess availability.
The foregoing description of amendment to the ABL Facility does not purport to be complete and is qualified in its entirety by
reference to the full text of the amendment to the ABL Facility. A copy of the amendment is attached as Exhibit 10.3 to this Form
XBRL Instance Document-the instance document does not appear in this Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
